Remoteness, race and social disadvantage: Disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia

Liver International

Volumn 35, Issue 12, 2015, Pages 2584-2594

  Clark, Paul J ^a,b,c   Stuart, Katherine A ^b   Leggett, Barbara A ^c,d   Crawford, Darrell H ^c   Boyd, Peter ^e   Fawcett, Jonathan ^b,c   Whiteman, David C ^a,c   Baade, Peter D ^c,f  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e CAIRNS BASE HOSPITAL   (Australia)

^f CANCER COUNCIL QUEENSLAND   (Australia)

Author keywords

Epidemiology; Geographical information system; Hepatocellular carcinoma; Liver cancer; Population based; Social determinants of disease

Indexed keywords

ADULT; AGE; AGED; ARTICLE; AUSTRALIA; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; ETHNICITY; FEMALE; GENDER; GEOGRAPHIC DISTRIBUTION; GEOGRAPHIC INFORMATION SYSTEM; HEALTH DISPARITY; HEPATITIS B; HUMAN; INDIGENOUS PEOPLE; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RACE; REGRESSION ANALYSIS; SEX DIFFERENCE; SOCIAL STATUS; SPATIAL ANALYSIS; YOUNG ADULT; CARCINOMA, HEPATOCELLULAR; DEMOGRAPHY; INCIDENCE; LIVER NEOPLASMS; PATHOLOGY; PROGNOSIS; QUEENSLAND; RISK FACTOR; SOCIOECONOMICS; SURVIVAL ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DEMOGRAPHY; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; QUEENSLAND; RISK FACTORS; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS;

EID: 84983134626     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12853     Document Type: Article

References (36)

1. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197-223.
2. Ferlay J, Shin H-R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
3. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142: 1264-73.e1.
4. Roberts SK, Kemp W. Hepatocellular carcinoma in an Australian tertiary referral hospital 1975-2002: change in epidemiology and clinical presentation. J Gastroenterol Hepatol 2007; 22: 191-6.
5. Sinclair M, Roberts S, Kemp W, et al. Epidemiology of hepatitis B-associated hepatocellular carcinoma in Victoria. Intern Med J 2013; 43: 501-6.
6. Amin J, Dore GJ, O'Connell DL, et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol 2006; 45: 197-203.
7. Kemp W, Pianko S, Nguyen S, Bailey MJ, Roberts SK. Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease. J Gastroenterol Hepatol 2005; 20: 873-81.
8. Kim Y, Ejaz A, Tayal A, et al. Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years. Cancer 2014; 120: 3058-65.
9. Thein HH, Walter SR, Gidding HF, et al. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007. J Viral Hepatitis 2011; 18: e232-41.
10. Walter SR, Thein H-H, Gidding HF, et al. Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C. J Gastroenterol Hepatol 2011; 26: 1757-64.
11. Baade P, Turrell G, Aitken J. A multilevel study of the determinants of area-level inequalities in colorectal cancer survival. BMC Cancer 2010; 10: 24.
12. Dasgupta P, Baade PD, Aitken JF, Turrell G. Multilevel determinants of breast cancer survival: association with geographic remoteness and area-level socioeconomic disadvantage. Breast Cancer Res Treat 2012; 132: 701-10.
13. Baade PD, Aitken JF, Ferguson M, Gardiner RA, Chambers SK. Diagnostic and treatment pathways for men with prostate cancer in Queensland: investigating spatial and demographic inequalities. BMC Cancer 2010; 10: 452.
14. Cramb S, Mengersen K, Baade P. Identification of area-level influences on regions of high cancer incidence in Queensland, Australia: a classification tree approach. BMC Cancer 2011; 11: 311.
15. Youlden DR, Baade PD, Valery PC, et al. Differentials in survival for childhood cancer in Australia by remoteness of residence and area disadvantage. Cancer Epidemiol Biomark Prev 2011; 20: 1649-56.
16. Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age Standardization of Rates: A New WHO Standard. Geneva: World Health Organization, 2001. GPE Discussion Paper Series 2001; No 31.
17. Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 1997; 16: 791-801.
18. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-51.
19. Goovaerts P. Geostatistical analysis of disease data: estimation of cancer mortality risk from empirical frequencies using Poisson kriging. Int J Health Geogr 2005; 4: 31.
20. Goovaerts P, Gebreab S. How does Poisson kriging compare to the popular BYM model for mapping disease risks? Int J Health Geogr 2008; 7: 6.
21. Statistics: ABo. Information Paper: An Introduction to Socio-Economic Indexes for Areas (SEIFA). Canberra: Commonwealth of Australia; 2008; ABS Cat. no. 2039.0.
22. Australian Institute of Health and Welfare. Rural, Regional and Remote Health: A Guide to Remoteness Classifications. Canberra: Canberra; 2004; AIHW Cat. No. PHE 53.
23. Goldstein ST, Zhou F, Hadler SC, et al. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34: 1329-39.
24. Cowie B. The linguistic demography of Australians living with chronic hepatitis B. Aust N Z J Public Health 2011; 35: 12-15.
25. Statistics ABo. Migration, Australia 2011-12 and 2012-13. Commonwealth of Australia. Canberra: Commonwealth of Australia; 2013; 3412.0.
26. MacLachlan JH, Cowie BC. Liver cancer is the fastest increasing cause of cancer death in Australians. Med J Aust 2012; 197: 492-3.
27. Hennekens CH, Buring JE, Mayrent SL, Doll R. Epidemiology in Medicine. Boston: Little, Brown, 1987.
28. Yu XQ, Luo Q, Smith DP, O'Connell DL, Baade PD. Geographic variation in prostate cancer survival in New South Wales. Med J Aust 2014; 200: 586-90.
29. Baade PD, Dasgupta P, Aitken JF, Turrell G. Distance to the closest radiotherapy facility and survival after a diagnosis of rectal cancer in Queensland. Med J Aust 2011; 195: 350-4.
30. Kaufman JS, Cooper RS, McGee DL. Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology (Cambridge, Mass) 1997; 8: 621-8.
31. Preston-Thomas A, Fagan P, Nakata Y, Anderson E. Chronic hepatitis B-care delivery and patient knowledge in the Torres Strait region of Australia. Aust Fam Physician 2013; 42: 225-31.
32. Cross V, Larkins S. Management of chronic Hepatitis B infection in the remote primary health care setting: the search for a suitable guideline. Aust J Rural Health 2011; 19: 95-100.
33. Smith KB, Humphreys JS, Wilson MGA. Addressing the health disadvantage of rural populations: how does epidemiological evidence inform rural health policies and research? Aust J Rural Health 2008; 16: 56-66.
34. Valery P, Coory M, Stirling J, Green A. Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study. Lancet 2006; 367: 1842-8.
35. Condon JR, Zhang X, Baade P, et al. Cancer survival for Aboriginal and Torres Strait Islander Australians: a national study of survival rates and excess mortality. Popul Health Metr 2014; 12: 1.
36. Arora S, Thornton K, Murata G, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011; 364: 2199-207.